The global M&A market declined significantly during the Covid-19 pandemic. This has also been reflected in transactions in the life sciences sector. However, our expert Christian Klingbeil assumes that the transaction market will recover quite quickly – first acquisitions can already be observed again. In this video, he explains how the transaction strategy of life sciences companies looks like in the new reality.